Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Sezary Syndrome 1Neuroblastoma 1Mycosis Fungoides 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Mycophenolic Acid 7fludarabine phosphate 6Radiotherapy 6Cyclophosphamide 6Antilymphocyte Serum 6Rituximab 5Peripheral Blood Stem Cell Transplantation 5Filgrastim 5Cyclosporine 5Whole-Body Irradiation 4Tacrolimus 4Flow Cytometry 4Etoposide 4Cord Blood Stem Cell Transplantation 4Busulfan 4tanespimycin 3Methotrexate 3Melphalan 3Lenalidomide 3Bortezomib 3plerixafor 2nelarabine 2mogamulizumab 2aldesleukin 2Vincristine 2Polymerase Chain Reaction 2Photopheresis 2Moxifloxacin 2Magnetic Resonance Spectroscopy 2Immunosuppression Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Sezary Syndrome × Interleukin-12 Subunit p35 × Clear all
NCT00052377 2013-01-16

Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides

National Cancer Institute (NCI)

Phase 1/2 Terminated
46 enrolled
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡